Primary Options for Acute Care: Management of Adult Cellulitis
|
|
- Hilda Harris
- 8 years ago
- Views:
Transcription
1 Primary Options for Acute Care: Management of Adult Cellulitis These guidelines provide support for IV Management of Cellulitis in the community for initial oral treatment has failed. This is to be used for guidance only and should not replace clinical judgment. Exclusion Criteria Inclusion Criteria An adult Clear diagnosis of Cellulitis Requiring IV antibiotic therapy Medically stable Satisfactory social & environmental circumstances Remember Funding does not cover ACC cases Disclaimer This guideline, which has been endorsed by the Microbiology Department, Middlemore Hospital, is intended to assist clinical decision making and provide General Practitioners with guidance on the appropriate use of the CMDHB and ADHB funded Primary Options Services. It is not entirely inclusive or exclusive of all methods of reasonable care. It should not replace professional clinical judgment in managing each individual patient. Confirm Cellulitis Mark area of erythema with marker Laboratory Investigations FBC ESR or CRP Electrolytes, glucose, Creatinine 2x blood cultures A swab if the lesion is discharging Therapy If no history of immediate penicillin hypersensitivity and not known to be an MRSA carrier: Cephazolin 2gm daily IV plus oral Probenecid 500mg twice daily OR Flucloxacillin 2gm q6h IV If history of immediate penicillin hypersensitivity: Clindamycin 300mg qid orally If a known MRSA carrier: If there is no response to oral antibiotic to which the MRSA is susceptible (eg Cotrimoxazole or Clindamycin, depending on proven susceptibility), refer to hospital for IV Vancomycin Admission is recommended for people with: Signs of haemodynamic instability - tachycardia - relative hypotension - severe dehydration - extreme or worsening pain or swelling - circulation is compromised Unstable co-morbidities such as heart failure, diabetes A drainable collection that requires surgeon to drain Monitor for potential complications An animal or human bite Post-orbital or peri-orbital cellulitis, unless a skin lesion is obvious Local suppuration and skin necrosis Bacteraemia Thrombophlebitis, particularly of the lower limbs Recurrent cellulitis may cause local, persistent lymphoedema Clostridium difficile Switching back to oral antibiotics Review in 48 hours with the aim to initiate oral flucloxacillin 500mg 1gm qid, one hour before food of two hours after food in 48 hours. If starting oral antibiotics, give the third (48 hour) dose of Cephazolin and initiate the oral antibiotic on the same day. Bed rest and elevation of the area of Cellulitis is crucial to recovery 1 Primary Options for Acute Care: Guideline for Management of Adult Cellulitis
2 Introduction Cellulitis is a regular cause for admission to hospital, primarily for the administration of intravenous (IV) antibiotics. It is now possible for most adults with Cellulitis to be treated in the community through Primary Options. The following guideline provides information on the treatment of adult Cellulitis in the community and has been endorsed by the Middlemore Infectious Disease Team (Selwyn Lang et al). Background 1. Definition Cellulitis is diffuse, spreading, acute inflammation within solid tissues, characterised by hyperemia, WBC infiltration, and oedema without cellular necrosis or suppuration. 2. Cause The usual pathogens are Streptococcus pyogenes (group A β-haemolytic streptococcus) and Staphylococcus aureus. The incidence of Staphylococcus aureus is increasing Staphylococcus aureus usually causes superficial Cellulitis but is typically less extensive than that of streptococcal origin. It is more likely associated with open wound or cutaneous abscess, though differential diagnosis is difficult. Approximately 10% of Staphylococcus aureus may be β-lactam resistant (MRSA). Differential diagnoses such as a DVT is particularly difficult when oedema occurs in the lower limbs. Recurrent leg Cellulitis may be prevented by treating concomitant tinea pedis. 3. Symptoms & signs An acute infection of skin and soft tissue characterised by localised pain, swelling, tenderness, Erythema and warmth. Cellulitis is often, but not always, preceded by a skin problem such as trauma, cut, puncture wound, insect bite, ulceration, tinea pedis, and dermatitis. Areas of lymphoedema or other oedema seem particular susceptible. The skin is hot, red and oedematous, often with an infiltrated surface resembling an orange skin. Borders are usually indistinct, unlike in erysipelas in which the borders are sharply demarcated and raised. 4. General cares Elevating the limb is very important and is probably the main reason people who are hospitalised do better than in the community. Ensure that the person has complete bed-rest while at home. Mark the area of Erythema with indelible marker to monitor progress of the Cellulitis. 5. Potential complications Local suppuration and skin necrosis (occasional). Bacteraemia. Thrombophlebitis, particularly of the lower limbs. Recurrent Cellulitis may cause local, persistent lymphoedema. However, the prognosis is generally excellent 2 Primary Options for Acute Care: Guideline for Management of Adult Cellulitis
3 See drug monographs below for specific dosing in renal impairment, adverse effects and IV administration. 6. Monitor for potential complications Local suppuration and skin necrosis (occasional). Bacteraemia. Thrombophlebitis, particularly of the lower limbs. Recurrent Cellulitis may cause local, persistent lymphoedema. Clostridium difficile. As Cefazolin is a broad-spectrum antibiotic, infection with clostridium difficile should be considered if diarrhoea occurs. Provide the patient and / or caregivers with the Home Cellulitis Treatment patient information leaflet so they are aware when to report to the general practitioner. Methods of monitoring that may help the patient decide whether to contact the general practitioner sooner than the 24 hours in which they would normally be checked include marking the inflamed area to monitor any spread. 7. Monitor for improvement Review the person within 24 hours (at the time of the next antibiotic dose), although if you have concerns about the domestic environment or think the person may be unduly anxious, a telephone call from the general practitioner or practice nurse sooner than this is recommended. If a person has a Streptococcus pyogenes Cellulitis the infection may be improving but the symptoms such as redness and inflammation may continue to progress because of the prior tissue damage (like sunburn, the tissue damage occurs during the day but the Erythema and pain presents later in the evening). This makes evaluation difficult but if there is any doubt, referral to the hospital is recommended. Switching back to oral antibiotics The patient should be reviewed with the aim to initiate oral antibiotics in 48 hours (i.e. after 2 doses of IV therapy, and prior to the third dose). If it is decided to start oral antibiotics, give the third (48 hours) dose of Cefazolin and start the oral antibiotic that day. Oral antibiotics are ideally Flucloxacillin 500 mg 1 gm four times daily one hour before food or two hours after. Oral antibiotics are suitable if: Temperature < 38 C for > 24 hours Clinical (redness / swelling) and laboratory (WCC, blood pressure, heart rate, respiration) signs of improvement Drug Monographs (Please refer to New Ethicals or MIMs for full product information) 1. Cefazolin Do not use in people with a previous hypersensitivity to cephalosporins or in people who have experienced an immediate or severe hypersensitivity reaction to penicillins. As seizures may occur in overdose, Cefazolin should be used cautiously in people with a history of seizures, particularly if renal impairment is present. 3 Primary Options for Acute Care: Guideline for Management of Adult Cellulitis
4 There are inadequate studies of Cefazolin in pregnancy to enable a recommendation regarding safety however there is no evidence of any risk. Creatinine clearance 35 ml/min, use Cefazolin 2 gm IV daily + Probenecid 500mg oral twice daily. Creatinine clearance ml/min, first dose of 2 gm IV daily + Probenecid 500 mg oral twice daily, with the second dose being 1gm Cefazolin + Probenecid 500 mg bd. For creatinine clearance 10 ml/min, likely admitted to hospital because of complicating renal failure. See below for equation to calculate creatinine clearance. IV administration Dilute each 1gm of Cefazolin in a minimum of 10ml sterile water for injection (total 20ml for 2 gm dose) and inject slowly over at least 5 minutes into the butterfly. Intermittent Infusion (Minibag or Burette Type Set): Prepare solution as for IM injection. Add the required dose to ml of compatible IV fluid (usually 500 or 100ml). Discard any solution that has not been used in 24 hours. Administer over minutes. Adverse effects Nausea and vomiting have been reported, though are uncommon. Similarly anorexia, diarrhoea and oral candidiasis have been reported. Pseudomembranous colitis has been reported with virtually all broad-spectrum antibiotics and so it is important to consider it in patients who develop diarrhoea while on Cefazolin. If the person has a history of antibiotic-induced candidiasis then prophylactic antifungal therapy should be considered. 2. Clindamycin People who have previously been hypersensitive to Clindamycin or Lincomycin. Safety in pregnancy has not been established however there is no evidence of any risk. Clindamycin does appear in breast milk in concentrations of µg/ml. Not necessary Oral administration 300 mg four times daily, taken with a full glass of water to avoid oesophageal irritation. Adverse effects Because Clindamycin has a moderate risk of causing pseudomembranous colitis, this should be considered if the person develops diarrhoea. A stool culture for Clostridium difficile and a stool assay for Clostridium difficile toxin is diagnostically helpful. Abdominal pain, nausea, skin rash, rarely polyarthritis. 4 Primary Options for Acute Care: Guideline for Management of Adult Cellulitis
5 3. Flucloxacillin Insert from NZHPA handbook on injectable drugs Do not use in people with a previous hypersensitivity to cephalosporins or penicillins. Each Gram of Flucloxacillin contains 2.2mmol of Sodium Use with caution in people with evidence of hepatic dysfunction Adjust dose in severe renal impairment. If creatinine clearance is < 15ml/min, likely admission to hospital because of complicating renal impairment. See below for equation to calculate creatinine clearance. IV Administration (into vein or side arm) Add 5 mls of Water to 250mgs or 500mg or 1G vial. Shake gently until all powder is dissolved. Withdraw contents and dilute contents with Water for Injection in the syringe to 10ml for the 250mg and 500mg vials, or to 10-20ml for the 1g vial. Inject slowly over 3-5 minutes. Intermittent Infusion: (Minibag or Burette type set) Prepare as for direct IV injection. Add required dose to 100 ml of compatible IV fluid. Infuse over 30 minutes. Continuous Infusion: Not recommended by this Method Stability: (After reconstitution or dilution) It is recommended that solutions for IM or direct IV injection be prepared immediately before use, and that dilutions in IV fluids be used within 1 hour of preparation. Compatibility Data Compatible with the following IV fluids 0.9% Sodium Chloride Dextran solutions 5% Glucose Glucose and Sodium Chloride Lactated Ringers (Hartmann s) Ringers Injection Do NOT add to blood products, amino-acid solutions or IV fat emulsions. Do NOT mix with any other medications. Adverse Effects Hypersensitivity reactions: rash, urticaria, purpura, fever, eosinophilia and sometimes anaphylaxis. GI disturbances, including (rarely) clostridium difficile. Cholestatic jaundice is the predominant sign of hepatotoxicity, usually with treatment longer than 2 weeks and in older people. This reaction may be delayed up to 2 months. Other Information 1. Use with caution in patients who are sensitive to Cephalosporins. 2. Hypersensitivity to penicillins is an absolute contraindication. 5 Primary Options for Acute Care: Guideline for Management of Adult Cellulitis
6 3. Each Gram contains approximately 2mmol (46.6mg) Na+ 4. PH of 5-7 when reconstituted as a 10% solution in water. 4. Probenecid People with blood dyscrasias or uric acid kidney stones Do not use in people with an acute episode of gout Use with caution in people with a history of peptic ulcer disease Probenecid does cross the placenta Probenecid decreases the excretion of Methotrexate Probenecid may increase the serum concentrations of NSAIDs, Lorazepam, Acyclovir Nil Oral administration 500 mg twice daily Adverse effects Headache, nausea, anorexia, pruritus, fever, flushing Calculation of creatinine clearance Creatinine clearance (ml/min) = (140-age) x Lean Body Weight (kg) x 60 x 0.85 (for women) 50,000 x s.creatinine (mmol/l) 6 Primary Options for Acute Care: Guideline for Management of Adult Cellulitis
7 Cellulitis IV Antibiotic Treatment (where POAC Guidelines are being followed) Schedule One: Use this schedule for Cephazolin where practice has purchased the antibiotics. Schedule Two: Use this schedule when using Flucloxacillin (strictly 6 hourly) or when POAC pays for antibiotics directly to pharmacy. Per Day Per Day Day 1 $ $ Day 2 and Day 3 $93.00 $73.00 Admin Fee $15.50 TOTAL $ $ Where deemed clinically necessary, POAC will fund an additional day (to a maximum of the Day 2/3 fees) without prior approval needing to be sought. However, we expect the amount charged to reflect the work undertaken, as some patients may require further IV therapy whilst for others, a brief clinical review may be sufficient. Any additional days of IV antibiotic treatment must be approved by the POAC office on a dose by dose basis. Approval for extension above the fifth dose will be given only where the GP has discussed with an Infectious Disease Consultant. 7 Primary Options for Acute Care: Guideline for Management of Adult Cellulitis
POAC CLINICAL GUIDELINE
POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol
PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.
More information2 What you need to know before you have Ampiclox
Reason for update: GDS 14 & QRD Updates Response to questions for variation update section 4.1 of SPC MHRA Submission Date: 6 November 2014 MHRA Approval Date: Text Date: October 2014 Text Issue and Draft
More informationCOMPOSITION: Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.
APPROVED PACKAGE INSERT DALACIN C 150 mg CAPSULES SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): DALACIN C TM 150 mg (Capsules) COMPOSITION: Each capsule contains clindamycin hydrochloride equivalent
More informationpatient group direction
DICLOFENAC v01 1/8 DICLOFENAC PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner
More informationBeaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject
Beaumont Hospital Department of Nephrology and Renal Nursing Guideline Name: Guideline for administering Ferinject Guideline Number: 18 Guideline Version: a Developed By: Louise Kelly CNM 1 Renal Day Care
More informationPATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN
PATIENT INFORMATION LEAFLET CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.
More informationCare Pathway for the Administration of Intravenous Iron Sucrose (Venofer )
Departments of Haematology, Nephrology and Pharmacy Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) [Care Pathway Review Date] Guidance for use This Care Pathway is intended
More informationAntibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Contents
Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine
More informationLung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC)
Indication: NICE TA181 First line treatment option in advanced or metastatic non-squamous NSCLC (histology confirmed as adenocarcinoma or large cell carcinoma) Performance status 0-1 Regimen details: Pemetrexed
More informationTHE OUT-OF-HOSPITAL CELLULITIS PATHWAY
THE OUT-OF-HOSPITAL CELLULITIS PATHWAY Post holder responsible for Policy: Directorate/Department responsible for Policy: Contact details: Hugh Bakere Acute Medicine Hugh Bakere, Consultant EMU, x6261
More informationMastitis and Breast Abscess
1. Purpose This document outlines the guidelines for pharmacological and non pharmacological management of mastitis and breast abscess at the Women s. This guideline is related to the RWH Breastfeeding
More informationLothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS
MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,
More information3% Sodium Chloride Injection, USP 5% Sodium Chloride Injection, USP
PRESCRIBING INFORMATION 3% Sodium Chloride Injection, USP 5% Sodium Chloride Injection, USP IV Fluid and Electrolyte Replenisher Baxter Corporation Mississauga, Ontario L5N 0C2 Canada Date of Revision:
More informationPHENYLEPHRINE HYDROCHLORIDE INJECTION USP
PRESCRIBING INFORMATION PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 10 mg/ml Sandoz Canada Inc. Date of Preparation: September 1992 145 Jules-Léger Date of Revision : January 13, 2011 Boucherville, QC, Canada
More informationCellulitis. Patient Information Leaflet. Contact numbers. Out of hours contact numbers
Contact numbers District Nurse: Intermediate Care Team: Your GP: Out of hours contact numbers District Nurse: Intermediate Care Team: Out of hours GP Service: If you would like this information in another
More informationEpidural Continuous Infusion. Patient information Leaflet
Epidural Continuous Infusion Patient information Leaflet April 2015 Introduction You may already know that epidural s are often used to treat pain during childbirth. This same technique can also used as
More informationPackage leaflet: Information for the patient. Laxido Orange, powder for oral solution
Package leaflet: Information for the patient Laxido Orange, powder for oral solution Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Paracetamol...10.00 mg for 1 ml of solution for infusion
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Paracetamol...10.00 mg for 1 ml of
More informationSTANDARD OPERATING PROCEDURE. Administration of High Dose Muscular Vitamin Supplements for Undergoing Alcohol
STANDARD OPERATING PROCEDURE Administration of High Dose Muscular Vitamin Supplements for Undergoing Alcohol DOCUMENT CONTROL: Version: 2 Ratified by: Clinical Effectiveness Committee Date ratified: 03
More informationPerfalgan 10 mg/ml, solution for infusion
PACKAGE LEAFLET: INFORMATION FOR THE USER Perfalgan 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need
More informationINTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline
Acknowledgements Background Well child with normal hydration Unwell children (+/- abnormal hydration Maintenance Deficit Ongoing losses (e.g. from drains) Which fluid? Monitoring Special Fluids Post-operative
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale
More informationDocetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer
Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer Background: A non-anthracycline based regimen for high-risk, HER 2 positive breast cancer in the adjuvant setting (BCIRG 006). Patient
More informationLEFLUNOMIDE (Adults)
Shared Care Guideline DRUG: Introduction: LEFLUNOMIDE (Adults) Indication: Disease modifying drug for rheumatoid arthritis and psoriatic arthritis Licensing Information: Disease modifying drug for active
More informationINTRAVENOUS DRUG QUICKGUIDE
INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION
More informationTo Order, Visit the Purchasing Page for Details
Go Back to the Top To Order, Visit the Purchasing Page for Details Chapter Bacterial Infections Cutaneous bacterial infections are caused by resident or transient bacteria in the epidermis and mucosa.
More informationPaediatric fluids 13/06/05
Dr Catharine Wilson Consultant Paediatric Anaesthetist Sheffield Children s Hospital. UK Paediatric fluids 13/06/05 Self assessment: Complete these questions before reading the tutorial. Discuss the answers
More informationOther Causes of Fever
T e c h n i c a l S e m i n a r s Other Causes of Fever Febrile Illness Causes Fever After Seven Days Referral Relapsing Fever - Borreliosis Overview JHR Adaptation Sore Throat Overview Prevention Management
More informationThis regimen has low emetogenic potential refer to local protocol None required routinely. Baseline results valid for 7 days. Results valid for 72 hrs
Regimen : Ipilimumab for Advanced Melanoma ICD10 code Codes pre-fixed with C43. Indication Regimen detail Ipilimumab is recommended as an option for treating advanced (unresectable or metastatic) melanoma
More informationAmylase and Lipase Tests
Amylase and Lipase Tests Also known as: Amy Formal name: Amylase Related tests: Lipase The Test The blood amylase test is ordered, often along with a lipase test, to help diagnose and monitor acute or
More informationEastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families
Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Omeprazol XXX 40 mg powder for solution for infusion omeprazole
PACKAGE LEAFLET: INFORMATION FOR THE USER Omeprazol XXX 40 mg powder for solution for infusion omeprazole Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They
More informationI B2.4. Design of the patient information leaflet for VariQuin
(English translation of official Dutch version) I B2.4. Design of the patient information leaflet for VariQuin Information for the Patient: Read this package leaflet carefully when you have some time to
More informationBlue Team Teaching Module: Periorbital/Orbital Infections
Blue Team Teaching Module: Periorbital/Orbital Infections Format: 1. Case 2. Topic Summary 3. Questions 4. References Case: A 3-year-old boy presents with 2 days of increasing redness, swelling, and pain
More informationTreatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia
Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Document Information Version: 2 Date: June 2014 Authors (incl. job title): Professor David Rees, Sue Height (consultant
More informationPatient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust.
Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust. This Patient Group Direction (PGD) has been written
More informationHyperosmolar Non-Ketotic Diabetic State (HONK)
Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis
More information17. Undiagnosed lumps and bumps and unexplained areas of pain. 2. Varicose veins (do not treat anything below the vein site).
15. Acute rheumatism. 16. Asthma. 17. Undiagnosed lumps and bumps and unexplained areas of pain. 18. Whiplash. 19. Slipped Disc. LOCAL CONTRA-INDICATIONS 1. Skin diseases (non contagious). 2. Varicose
More informationMENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals
MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals What is Bexsero vaccine? Bexsero is a meningococcal Group B (MenB) vaccine which is indicated for the active immunisation of
More informationPACKAGE LEAFLET. CLINDAMYCIN capsules Clidamycin. One capsule of 75 mg contains 75 mg Clindamycin (as hydrochloride).
PACKAGE LEAFLET CLINDAMYCIN capsules Clidamycin COMPOSITION One capsule of 75 mg contains 75 mg Clindamycin (as hydrochloride). One capsule of 150 mg contains 150 mg Clindamycin (as hydrochloride). PROPERTIES
More informationTreatment of sexually transmitted and other genital infections
www.bpac.org.nz keyword: sti Treatment of sexually transmitted and other genital infections Key reviewer: Dr Murray Reid, Sexual Health Physician, Auckland Sexual Health Service General points: If one
More informationMedications or therapeutic solutions may be injected directly into the bloodstream
Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals
More informationYes This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.
Title: Patient Group Direction for the administration of lidocaine hydrochloride 1% injection as infiltration anaesthesia for insertion/removal of central venous catheters by nurses/radiographers working
More informationEnoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants
Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Relevant Licensed Indications
More informationUpstate University Health System Medication Exam - Version A
Upstate University Health System Medication Exam - Version A Name: ID Number: Date: Unit: Directions: Please read each question below. Choose the best response for each of the Multiple Choice and Medication
More informationNHS FORTH VALLEY Guidelines for use of high dose Intravenous Esomeprazole in Adults (Previously called the Hong Kong Protocol)
NHS FORTH VALLEY Guidelines for use of high dose Intravenous Esomeprazole in Adults (Previously called the Hong Kong Protocol) Date of First Issue 10/05/2010 Approved 16/06/2010 Current Issue Date 18/11/2015
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationAlways take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.
leaflet: Information for the user Macrogol 4000 10 g powder for oral solution in sachet Macrogol 4000
More informationWound Care on the Field. Objectives
Wound Care on the Field Brittany Witte, PT, DPT Cook Children s Medical Center Objectives Name 3 different types of wounds commonly seen in sports and how to emergently provide care for them. Name all
More informationGuideline for the use of subcutaneous hydration in palliative care (hypodermoclysis)
Guideline for the use of subcutaneous hydration in palliative care (hypodermoclysis) Date Approved by Network Governance September 2012 Date for Review September 2015 Page 1 of 7 1 Scope of Guideline 1.1
More informationThe format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013.
The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013 Havrix 720 Junior 1 NAME OF THE MEDICINAL PRODUCT Havrix 720 Junior 2 QUALITATIVE
More informationCEFA-DROPS AND CEFA-TABS
Page 1 of 5 FORT DODGE ANIMAL HEALTH Division of Wyeth 800-5TH STREET N.W., P.O. BOX 518 FORT DODGE IA 50501 USA Telephone: 515-955-4600 Fax: 515-955-3730 Order Desk Telephone: 800-685-5656 Order Desk
More informationInterpretation of Laboratory Values
Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances
More informationCalcium Folinate Ebewe Data Sheet
NAME OF THE MEDICINE Calcium folinate injection Composition Active: Calcium folinate (equivalent to 10 mg folinic acid per ml) Inactive: Sodium chloride (7.7mg/mL), qs Water for Injections. Preservative
More informationA4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)
A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) Types of Catheter Related Thrombotic A catheter-related thrombus may be intraluminal (inside the catheter)
More informationLung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC)
Lung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC) Indication: In combination with docetaxel in locally advanced, metastatic or locally recurrent NSCLC of adenocarcinoma
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationRheumatoid Arthritis. GP workshop 15 January 2011
Rheumatoid Arthritis GP workshop 15 January 2011 Case 1 A 72 year old Malay woman with RA comes for routine follow up. She feels generally unwell in the last 5 days. Appetite is fair. Her joints are fine.
More informationMaintenance of abstinence in alcohol dependence
Shared Care Guideline for Prescription and monitoring of Acamprosate Calcium Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist, Alcohol Services Dr Donnelly
More informationSECTION 6 THERAPEUTIC DRUG MONITORING
SECTION 6 THERAPEUTIC DRUG MONITORING Kieran Hand Consultant Pharmacist Anti-infectives The objectives of this section are: To test your ability to monitor serum levels for drugs with a narrow therapeutic
More informationVIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES
VIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES INTRODUCTION This is the protocol and procedures to administer VIVITROL (extended-release naltrexone injection, or XR-NTX)
More informationChapter 15. Reconstitution and Dosages Measured in Units. Copyright 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved.
Chapter 15 Reconstitution and Dosages Measured in Units 1 Objectives Calculating drug dosage problems that first require reconstitution of a powdered drug into a liquid form Using a proportion to solve
More informationThioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid
Package Leaflet: Information for the User Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid For use in adults Active substance: Alpha-lipoic acid, Trometamol salt (1:1) Read all
More informationINITIATING ORAL AUBAGIO (teriflunomide) THERAPY
FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been
More informationVAD Chemotherapy Regimen for Multiple Myeloma Information for Patients
VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients The Regimen contains: V = vincristine (Oncovin ) A = Adriamycin (doxorubicin) D = Decadron (dexamethasone) How Is This Regimen Given?
More informationRivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)
Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE) Amber Drug Level 2 Leeds We have started your patient on rivaroxaban for the treatment of provoked VTE (deep
More informationDabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF
Leeds Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your
More informationADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS
SASKATOON DISTRICT HEALTH Department of Nursing Affairs ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS SPECIAL NURSING PROCEDURE LEARNING PACKAGE This package provides the basic information necessary
More informationPackage leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride
A leaflet will be included in each pack. The leaflet will consist of a Technical Information Leaflet and a Patient Information Leaflet. The two leaflets will be easily separatable. The text of the Technical
More informationInformation for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?
Information for you Treatment of venous thrombosis in pregnancy and after birth Published in September 2011 What is venous thrombosis? Thrombosis is a blood clot in a blood vessel (a vein or an artery).
More informationReconstitution of Solutions
Chapter 12 Reconstitution of Solutions Reconstitution Process of mixing and diluting solutions Some medications supplied in powder form and must be mixed with liquid before administration Parts of Solutions
More informationAntibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis
Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis ANTIBIOTIC-ASSOCIATED DIARRHEA Disturbance of the normal colonic microflora Leading to alterations in bacterial degradation
More informationWard 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home
Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home Contents Page Important contact numbers 1 General information on preparing and administering IV antibiotics
More informationRivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF
Leeds Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your
More informationA. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS
SUBCUTANEOUS THERAPY A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS PARTS I. Purposes II. General Information III. Responsibilities IV.
More informationDevelop an understanding of the differential diagnosis of pseudomembranous colitis
Update on Clostridium difficile Colitis Clostridium difficile infection has recently emerged in populations without any known risk factors. This presentation will focus on the historical background, diagnosis,
More informationPeripherally Inserted Central Catheter (PICC) for Outpatient
Peripherally Inserted Central Catheter (PICC) for Outpatient Introduction A Peripherally Inserted Central Catheter, or PICC line, is a thin, long, soft plastic tube inserted into a vein of the arm. It
More informationDiabetic Ketoacidosis
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Diabetic Ketoacidosis Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should
More informationAcute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.
The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal
More informationResource Document 6: Tetanus Immunization. I. Introduction
Resource Document 6: Tetanus Immunization I. Introduction Attention must be directed to adequate tetanus prophylaxis in the multiply injured patient, particularly if open-extremity trauma is present. The
More informationCarla Duff, CPNP MSN CCRP Clinical Advanced Registered Nurse Practitioner University of South Florida Division of Allergy, Immunology, and
Carla Duff, CPNP MSN CCRP Clinical Advanced Registered Nurse Practitioner University of South Florida Division of Allergy, Immunology, and Rheumatology Intravenous Subcutaneous IVIg SCIg What should you
More informationEarly Access to Medicines Scheme Treatment protocol Information for patients
Early Access to Medicines Scheme Treatment protocol Information for patients Introduction The aim of the Early Access to Medicines Scheme (EAMS) is to provide earlier availability of promising new unlicensed
More informationHuman Normal Immunoglobulin Solution for Intravenous Infusion.
CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM Human Normal Immunoglobulin Solution for Intravenous Infusion. OCTAGAM is available in single use bottles of 20 ml, 50 ml, 100 ml and 200 ml. OCTAGAM contains
More informationEuropean Medicines Agency recommends restricting use of trimetazidine-containing medicines
22 June 2012 EMA/CHMP/417861/2012 Press Office Press release European Medicines Agency recommends restricting use of trimetazidine-containing medicines Restricted indication for patients with stable angina
More informationDiabetic Emergencies. David Hill, D.O.
Diabetic Emergencies David Hill, D.O. Class Outline Diabetic emergency/glucometer training Identify the different signs of insulin shock Diabetic coma, and HHNK Participants will understand the treatment
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More information1.3.1.3 PACKAGE LEAFLET
Sandoz Business use only Page 1 of 8 1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 2 of 8 Package leaflet: Information for the patient Cefuhexal 250 mg film-coated tablets Cefuhexal 500 mg film-coated
More informationPackage leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab
Package leaflet: Information for the patient Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab This medicine is subject to additional monitoring. This will allow quick identification
More informationClinical Performance Director of Nursing Allison Bussey
PGD 0314 Patient Group Direction Administration of Adrenaline (Epinephrine) 1:1000 (1mg/ml) Injection By Registered Nurses employed by South Staffordshire & Shropshire Healthcare Foundation NHS Trust This
More informationNursing Process Focus: Patients Receiving LINDANE (Kwell)
Nursing Process Focus: Patients Receiving LINDANE (Kwell) ASSESSMENT Prior to administration: Obtain complete health history including allergies, drug history, and possible drug interactions. Assess vital
More informationGloucestershire Hospitals
Gloucestershire Hospitals NHS Foundation Trust TRUST GUIDELINE INFLIXIMAB PRESCRIBING AND ADMINISTRATION 1. INTRODUCTION Infliximab is an anti-tumour necrosis factor-α (Anti-TNF) antibody. It is from a
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationGuideline for the Management of Nephrotic Syndrome
Guideline for the Management of Nephrotic Syndrome Renal Unit Royal Hospital for Sick Children Yorkhill Division Please note: the following guideline has not been assessed according to the AGREE (Appraisal
More information160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection.
160S01105, Page 1 of 7 New Zealand Data Sheet Hepatitis B Immunoglobulin-VF NAME OF THE MEDICINE Human Hepatitis B Immunoglobulin, solution for intramuscular injection. DESCRIPTION Hepatitis B Immunoglobulin-VF
More informationChemoembolization for Patients with Pancreatic Neuroendocrine Tumours
Chemoembolization for Patients with Pancreatic Neuroendocrine Tumours What is this cancer? Pancreatic Endocrine Tumours are also called Pancreatic Neuroendocrine Tumours. This cancer is rare and it starts
More informationFemoral Hernia Repair
Femoral Hernia Repair WHAT IS A FEMORAL HERNIA REPAIR? 2 WHAT CAUSES A FEMORAL HERNIA? 2 WHAT DOES TREATMENT/ MANAGEMENT INVOLVE? 3 DAY SURGERY MANAGEMENT 3 SURGICAL REPAIR 4 WHAT ARE THE RISKS/COMPLICATIONS
More informationAcute pelvic inflammatory disease: tests and treatment
Acute pelvic inflammatory disease: tests and treatment Information for you Information for you Published August 2010 Published in August 2010 (next review date: 2014) Acute What is pelvic inflammatory
More informationClostridium Difficile Colitis: Treatments, Guidelines, and Challenges
Clostridium Difficile Colitis: Treatments, Guidelines, and Challenges Brian S. Zuckerbraun, MD, FACS Henry T. Bahnson Professor of Surgery University of Pittsburgh Chief, Trauma and Acute Care Surgery
More information